Marinus Pharma Stock (NASDAQ: MRNS) stock price, news, charts, stock research, profile.
Open | $1.450 |
Close | $1.440 |
Volume / Avg. | 2.861M / 1.639M |
Day Range | 1.395 - 1.560 |
52 Wk Range | 1.110 - 11.260 |
Market Cap | $80.194M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 15 |
Short Interest | 6.35% |
Days to Cover | 8.15 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Marinus Pharma (NASDAQ: MRNS) through any online brokerage.
Other companies in Marinus Pharma’s space includes: SCYNEXIS (NASDAQ:SCYX), Jaguar Health (NASDAQ:JAGX), CalciMedica (NASDAQ:CALC), Ocuphire Pharma (NASDAQ:OCUP) and Cara Therapeutics (NASDAQ:CARA).
The latest price target for Marinus Pharma (NASDAQ: MRNS) was reported by Truist Securities on Wednesday, April 17, 2024. The analyst firm set a price target for 10.00 expecting MRNS to rise to within 12 months (a possible 584.98% upside). 27 analyst firms have reported ratings in the last year.
The stock price for Marinus Pharma (NASDAQ: MRNS) is $1.4599 last updated Today at April 23, 2024 at 4:39 PM EDT.
There are no upcoming dividends for Marinus Pharma.
Marinus Pharma’s Q1 earnings are confirmed for Thursday, May 9, 2024.
There is no upcoming split for Marinus Pharma.
Marinus Pharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.